97 related articles for article (PubMed ID: 27750143)
21. The 5α-reductase inhibitor finasteride reduces opioid self-administration in animal models of opioid use disorder.
Bosse GD; Cadeddu R; Floris G; Farero RD; Vigato E; Lee SJ; Zhang T; Gaikwad NW; Keefe KA; Phillips PE; Bortolato M; Peterson RT
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33848264
[TBL] [Abstract][Full Text] [Related]
22. Finasteride Has Regionally Different Effects on Brain Oxidative Stress and Acetylcholinesterase Activity in Acute Thioacetamide-Induced Hepatic Encephalopathy in Rats.
Mladenović D; Petronijević N; Stojković T; Velimirović M; Jevtić G; Hrnčić D; Radosavljević T; Rašić-Marković A; Maksić N; Djuric D; Stanojlović O
PLoS One; 2015; 10(8):e0134434. PubMed ID: 26241899
[TBL] [Abstract][Full Text] [Related]
23. Effects of oral finasteride on erectile function in a rat model.
Zhang MG; Wu W; Zhang CM; Wang XJ; Gao PJ; Lu YL; Shen ZJ
J Sex Med; 2012 May; 9(5):1328-36. PubMed ID: 22375859
[TBL] [Abstract][Full Text] [Related]
24. A 5α-reductase inhibitor, finasteride, increases differentiation and proliferation of embryonal carcinoma cell-derived-neural cells.
Shoae-Hassani A; Sharif S; Verdi J
Med Hypotheses; 2011 Jan; 76(1):11-3. PubMed ID: 20851532
[TBL] [Abstract][Full Text] [Related]
25. Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target.
Giatti S; Di Domizio A; Diviccaro S; Falvo E; Caruso D; Contini A; Melcangi RC
J Med Chem; 2021 Apr; 64(8):4553-4566. PubMed ID: 33843213
[TBL] [Abstract][Full Text] [Related]
26. Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase.
Youn DH; Park J; Kim HL; Jung Y; Kang J; Jeong MY; Sethi G; Seok Ahn K; Um JY
Oncotarget; 2017 Feb; 8(6):9500-9512. PubMed ID: 27880726
[TBL] [Abstract][Full Text] [Related]
27. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
[TBL] [Abstract][Full Text] [Related]
28. The 5α-reductase inhibitor finasteride is not associated with alterations in sleep spindles in men referred for polysomnography.
Goldstein MR; Cook JD; Plante DT
Hum Psychopharmacol; 2016 Jan; 31(1):70-4. PubMed ID: 26494125
[TBL] [Abstract][Full Text] [Related]
29. Uvaria rufa Blume attenuates benign prostatic hyperplasia via inhibiting 5α-reductase and enhancing antioxidant status.
Buncharoen W; Saenphet K; Saenphet S; Thitaram C
J Ethnopharmacol; 2016 Dec; 194():483-494. PubMed ID: 27732901
[TBL] [Abstract][Full Text] [Related]
30. Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model.
Lee G; Shin J; Choi H; Jo A; Pan S; Bae D; Lee Y; Choi C
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953224
[TBL] [Abstract][Full Text] [Related]
31. Finasteride-induced depression: new insights into possible pathomechanisms.
Römer B; Gass P
J Cosmet Dermatol; 2010 Dec; 9(4):331-2. PubMed ID: 21122055
[TBL] [Abstract][Full Text] [Related]
32. Finasteride treatment and neuroactive steroid formation.
Dusková M; Hill M; Hanus M; Matousková M; Stárka L
Prague Med Rep; 2009; 110(3):222-30. PubMed ID: 19655698
[TBL] [Abstract][Full Text] [Related]
33. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
Schwartz JI; Tanaka WK; Wang DZ; Ebel DL; Geissler LA; Dallob A; Hafkin B; Gertz BJ
J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
[TBL] [Abstract][Full Text] [Related]
34. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
[TBL] [Abstract][Full Text] [Related]
35. The influence of low dose finasteride, a type II 5α-reductase inhibitor, on circulating neuroactive steroids.
Dušková M; Hill M; Stárka L
Horm Mol Biol Clin Investig; 2010 Jan; 1(2):95-102. PubMed ID: 25961975
[TBL] [Abstract][Full Text] [Related]
36. The effect of 5alpha-reductase inhibition with finasteride and dutasteride on bone mineral density in older men with benign prostatic hyperplasia.
Mačukat IR; Spanjol J; Orlič ZC; Butorac MZ; Marinovič M; Ćupič DF
Coll Antropol; 2014 Sep; 38(3):835-9. PubMed ID: 25420363
[TBL] [Abstract][Full Text] [Related]
37. Treatment with and withdrawal from finasteride alter ethanol intake patterns in male C57BL/6J mice: potential role of endogenous neurosteroids?
Ford MM; Nickel JD; Finn DA
Alcohol; 2005 Aug; 37(1):23-33. PubMed ID: 16472716
[TBL] [Abstract][Full Text] [Related]
38. Proteomic analysis of the nucleus accumbens of rats with different vulnerability to cocaine addiction.
del Castillo C; Morales L; Alguacil LF; Salas E; Garrido E; Alonso E; Pérez-García C
Neuropharmacology; 2009 Jul; 57(1):41-8. PubMed ID: 19393250
[TBL] [Abstract][Full Text] [Related]
39. Combined effect of the finasteride and doxazosin on rat ventral prostate morphology and physiology.
Justulin LA; Acquaro C; Carvalho RF; Silva MD; Felisbino SL
Int J Androl; 2010 Jun; 33(3):489-99. PubMed ID: 19490185
[TBL] [Abstract][Full Text] [Related]
40. Neonatal allopregnanolone or finasteride administration modifies hippocampal K(+) Cl(-) co-transporter expression during early development in male rats.
Mòdol L; Casas C; Llidó A; Navarro X; Pallarès M; Darbra S
J Steroid Biochem Mol Biol; 2014 Sep; 143():343-7. PubMed ID: 24861264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
